Olema Pharmaceuticals (OLMA) Superinvestor holders
8 of the superinvestors we track hold Olema Pharmaceuticals (OLMA) in their latest 13F filings, $60M in total.
Summary
The largest holder is Mark Kingdon (Kingdon Capital Management), with $15M, 2.0% of the portfolio.
In their latest quarter: 1 opened a new position, 4 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Mark Kingdon Kingdon Capital Management |
Added | 1,200,000 | $15M | 2.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 1,131,434 | $14M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Added | 1,070,949 | $13M | 0.0% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
Held | 986,827 | $12M | 0.3% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 332,418 | $3M | 0.0% | Q3 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 78,161 | $977,794 | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 55,519 | $694,543 | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 22,100 | $276,471 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 8 |
| Q1 2026 | 12 |
| Q4 2025 | 14 |
| Q3 2025 | 6 |
| Q2 2025 | 5 |
| Q1 2025 | 7 |
| Q4 2024 | 6 |
| Q3 2024 | 6 |
Questions about Olema Pharmaceuticals
Which superinvestors own Olema Pharmaceuticals?
8 of the superinvestors we track hold Olema Pharmaceuticals (OLMA) in their latest 13F filings, $60M in total. Mark Kingdon, Two Sigma, Steve Cohen, Stanley Druckenmiller, Ken Fisher, Cliff Asness.
Who is the largest superinvestor holder of OLMA?
The largest holder is Mark Kingdon (Kingdon Capital Management), with $15M, 2.0% of the portfolio.
From Olema Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.